Medicine
Tamoxifen 20 mg tablet
Tamoxifen 20 mg tablet is a generic prescription medicine for oral use, made by 8 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Tamoxifen
- Brand
- Sold under the generic name
- Strength
- 20 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 30 tablets, 90 tablets, 1000 tablets and 11 more
- Manufacturers
- Aurobindo PharmaIndiaDr. Reddy's LaboratoriesIndiaProficient RxActavis PharmaMayne Pharma CommercialA-S Medication SolutionsBryant Ranch PrepackMylan Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- L02BA01 Tamoxifen
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 February 2003
- Identifiers
- RxCUI 198240, 313195DailyMed set ID c82205a3-ae0c-4ce5-b04b-9581cd8c70d4, bb53eeb7-83fc-469e-b9e3-df5f27bfec7b, 716657e8-d809-4671-87bc-8d10ef69a071 +5NDC 51862-643, 63187-976, 50090-0942 +5Application ANDA075797, ANDA070929, ANDA074732 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 30 tablet, film coated in 1 bottle | 59651-300-30 | Aurobindo PharmaIndia | 14 August 2020 |
| 90 tablet, film coated in 1 bottle | 59651-300-90 | Aurobindo PharmaIndia | 14 August 2020 |
| 1000 tablet, film coated in 1 bottle | 75907-059-10 | Dr. Reddy's LaboratoriesIndia | 22 August 2024 |
| 30 tablet, film coated in 1 bottle | 75907-059-30 | Dr. Reddy's LaboratoriesIndia | 22 August 2024 |
| 90 tablet in 1 bottle, plastic | 0591-2473-19 | Actavis Pharma | 15 August 2011 |
| 30 tablet in 1 bottle, plastic | 0591-2473-30 | Actavis Pharma | 15 August 2011 |
| 1000 tablet, film coated in 1 bottle | 51862-643-10 | Mayne Pharma Commercial | 27 August 2021 |
| 30 tablet, film coated in 1 bottle | 51862-643-30 | Mayne Pharma Commercial | 27 August 2021 |
| 30 tablet in 1 bottle | 0378-0274-93 | Mylan Pharmaceuticals | 20 February 2003 |
| 90 tablet in 1 bottle, plastic | 50090-0942-0 | A-S Medication Solutions | 28 November 2014 |
| 30 tablet, film coated in 1 bottle | 72162-2209-3 | Bryant Ranch Prepack | 5 January 2024 |
| 30 tablet in 1 bottle, plastic | 63187-976-30 | Proficient Rx | 1 February 2018 |
| 60 tablet in 1 bottle, plastic | 63187-976-60 | Proficient Rx | 1 February 2018 |
| 90 tablet in 1 bottle, plastic | 63187-976-90 | Proficient Rx | 1 February 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 30 December 1977 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Tamoxifen
Clinical summary
Tamoxifen is an estrogen agonist/antagonist indicated for treatment of adult patients with estrogen receptor-positive metastatic breast cancer, among other approved uses. It is available as tablets and oral liquid. MedsAcross supplies Tamoxifen for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about TamoxifenFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- SOLTAMOX prescribing information (Mayne Pharma) · U.S. National Library of Medicine, DailyMed
Need Tamoxifen 20 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.